The use of cyanoacrylate adhesives in the management of congenital vascular malformations

Seminars in Interventional Radiology

Volumn 21, Issue 1, 2004, Pages 59-66

  Rosen, Robert J ^a   Contractor, Sohail ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Congenital disease; Cyanoacrylates; Vascular malformation

Indexed keywords

ADHESIVE AGENT; ALCOHOL; CYANOACRYLATE; ENBUCRILATE; ETHIODIZED OIL; GELFOAM; IOFENDYLATE; MICROCRYSTALLINE COLLAGEN; OXIDIZED CELLULOSE; POLYVINYL ALCOHOL SPONGE; SCLEROSING AGENT; SILICONE;

ARTERIOVENOUS FISTULA; ARTICLE; ARTIFICIAL EMBOLISM; CATHETERIZATION; CHEMICAL STRUCTURE; COMPLICATION; CONGENITAL BLOOD VESSEL MALFORMATION; HUMAN; PHYSICAL CHEMISTRY; POLYMERIZATION; SAFETY; TREATMENT OUTCOME;

EID: 4043059193     PISSN: 07399529     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-831406     Document Type: Article

References (31)

1. Kerber CW, Wong W. Liquid acrylic adhesive agents interventional Neuroradiology. Neurosurg Clin N Am 2000;11:85-99
2. Ardis AE. U.S. Patent 2,467,926, 1949
3. Coover HW Jr, Joyner FB, Shearer NH Jr, et al. Chemistry and performance of cyanoacrylate adhesives. Soc Plast Eng J 1959;15:413-417
4. Barr JD, Hoffman EJ, Davis BR, Edgar KA, Jacobs CR. Microcatheter adhesion of cyanoacrylates, comparison of normal butyl cyanoacrylate to 2-hexyl cyanoacrylate. J Vasc Interv Radiol 1999;10:165-168
5. The n-BCA trial investigators AJNR Am J Neuroradiol 2002;23:748-755
6. Schweitzer JS, Chang BS, Madsen P, et al. The pathology of arteriovenous malformations of the brain treated by embolotherapy. Neuroradiology 1993;35:468-474
7. Toriumi DM, Raslan WF, Friedman M, Tardy ME. Histotoxicity of cyanoacrylate tissue adhesive: a comparative study. Arch Otolaryngol Head Neck Surg 1990;116:546-550
8. Galil KA, Schonfield ID, Wright GZ. Effect of butyl 2-cyanoacrylate on the healing of skin wounds. Can Dent Assoc J 1984;50:565-569
9. Petrella E, Orlandini G, Poisetti P, et al. A new end to side anastomosis formed without sutures for hemodialysis fistulas. Nephron 1975;14:398-400
10. O'Leary JA. Tissue adhesives and pelvic hemostasis: an evaluation of isobutyl 2-cyanoacrylate. J Surg Oncol 1971;3:117-120
11. Fogle JA, Kenyon KR, Foster CS. Tissue adhesive arrests stromal melting in the human cornea. Am J Ophthalmol 1980;89:795-802
12. Wilkinson TS, Rybka FJ. Experimental study of prevention of tip necrosis in schemic z-plasties. Plast Reconstr Surg 1971;47:37-38
13. Smyth GDL, Kerr AG. Histoacryl (butyl cyanoacrylate) as an ossicular adhesive. J Laryngol Otol 1974;88:539-542
14. Bhaskar SN, Frisch J, Margetis PM, Leonard F. Application of a new chemical adhesive in periodontic and oral surgery. Oral Surg 1966;22:526-535
15. Bank WO, Kerber CW, Cromwell LD. Rapidly polymerizing glue for the treatment of intracerebral arteriovenous malformations. In: Moss A, Goldberg H, eds. Interventional Radiological Techniques: Computed Tomography and Ultrasonography. San Francisco: University of California Press; 1981:83-92
16. Cromwell LD, Kerber CW. Modification of cyanoacrylate for therapeutic embolization: preliminary experience. AMJ Am J Roentgenol 1979;132:799-801
17. Spiegel SM, Vinuela F, Goldwasser JM, Fox AJ, Pelz DM. Adjusting the polymerazation of isobutyl-2 cyanoacrylate. AJNR Am J Neuroradiol 1986;7:109-112
18. Sadato A, Wakhloo AK, Hopkins LN. Effect of a mixture of a Low concentration of n-butylcyanoacrylate and Ethiodol on tissue reactions and the permanence of arterial occlusion after embolization. Neurosurgery 2000;47:1197-1203
19. Brothers MF, Kaufman JC, Fox AJ, Devekis JP. N-Butyl 2-cyanoacrylate- substitute for IBCA in interventional neuroradiology: histopathological and polymerization time studies. AJNR Am J Neuroradiol 1989;10:777-786
20. White RI Jr, Strandberg JV, Gross GS, Barth KH. Therapeutic embolization with long term occluding agents and their effects on embolized tissues. Radiology 1977;125:677-687
21. Vinters HV, Galil KA, Lundie MJ, Kaufman JC. The histotoxicity of cyanoacrylates: a selective review. Neuroradiology 1985;27:279-291
22. Wikholm G. Occlusion of cerebral arteriovenous malformations with N-butyl cyano-acrylate is permanent. AJNR Am J Neuroradiol 1995;16:479-482
23. Gruber A, Mazal PR, Bavinski G, Killer M, Budka H, Richling B. Repermeation of partially embolized cerebral arteriovenous malformations: a clinical, radiologic, and histologic study. AJNR Am J Neuroradiol 1996;17:1323-1331
24. Rao VR, Mandalam KR, Gupta AK, Kumar S, Joseph S. Dissolution of isobutyl 2-cyanoacrylate on long term follow up. AJNR Am J Neuroradiol 1989;10:135-141
25. Brown LC, Mellick PW, Smith CD, et al. Carcinogenicity bioassay of isobutyl 2-cyanoacrylate (IBC) in fischer-344 rats. NTIS/AD-A222 000/2, 1990
26. Brown LC, Mellick PW, Smith CD, et al. Carcinogenicity bioassay of isobutyl 2-cyanoacrylate in fischer-344 rats. Report: ISS LAIR-433, Toxicology ser-187, Order No. AD-A22 2000;1990:1161
27. Brown LC, Smith CD, Lollini LO, et al. Carcinogenicity bioassay of isobutyl 2-cyanoacrylate(IBC) in fischer-344 rats-one year interim sacrifice report, Vol. 1. NTIS/AD-A195 913/9; 1988
28. Brown LC, Smith CD, Lollini LO, et al. Carcinogenicity bioassay of isobutyl 2-cyanoacrylate(IBC) in fischer-344 rats-one year interim sacrifice report, Vol. 2, part 1. NTIS/AD-A201 448/8; 1989
29. Brown LC, Smith CD, Lollini LO, et al. Carcinogenicity bioassay of isobutyl 2-cyanoacrylate(IBC) in fischer-344 rats-one year interim sacrifice report. Vol. 2, part 2. NTIS/AD-A197 679/4; 1988
30. Debrun GM, Aletich V, Ausman JI, Charbel F, Dujovny M. Embolization of the nidus of brain arteriovenous malformations with n-butyl cyanoacrylate. Neurosurgery 1997;40:112-120
31. Kunstlinger F, Brunelle F, Chaumont P, Doyon D. Vascular occlusive agents. AJR Am J Roentgenol 1981;136:151-156